Article Details

Grünenthal closes deal with AstraZeneca for European rights to CRESTOR™ (rosuvastatin)

Retrieved on: 2021-02-10 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

Grünenthal closes deal with AstraZeneca for European rights to CRESTOR™ (rosuvastatin). View article details on hiswai:

Excerpt

Grünenthal closes deal with AstraZeneca for European rights to CRESTOR™ (rosuvastatin). News provided by. Grünenthal Group. Feb 10, 2021, 02:00 ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up